139 related articles for article (PubMed ID: 3386685)
1. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan.
King DL; Turco SJ
Mol Biochem Parasitol; 1988 Apr; 28(3):285-93. PubMed ID: 3386685
[TBL] [Abstract][Full Text] [Related]
2. Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani.
Huang C; Turco SJ
J Biol Chem; 1993 Nov; 268(32):24060-6. PubMed ID: 8226951
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies.
McNeely TB; Tolson DL; Pearson TW; Turco SJ
Glycobiology; 1990 Sep; 1(1):63-9. PubMed ID: 2136382
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a ricin-resistant mutant of Leishmania donovani that expresses lipophosphoglycan.
Phillips MR; Turco SJ
Glycobiology; 2015 Apr; 25(4):428-37. PubMed ID: 25472443
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of mannosylphosphate transfer in vitro.
Carver MA; Turco SJ
Arch Biochem Biophys; 1992 Jun; 295(2):309-17. PubMed ID: 1586160
[TBL] [Abstract][Full Text] [Related]
6. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major.
Elhay M; Kelleher M; Bacic A; McConville MJ; Tolson DL; Pearson TW; Handman E
Mol Biochem Parasitol; 1990 May; 40(2):255-67. PubMed ID: 2362605
[TBL] [Abstract][Full Text] [Related]
7. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.
McNeely TB; Turco SJ
J Immunol; 1990 Apr; 144(7):2745-50. PubMed ID: 2319134
[TBL] [Abstract][Full Text] [Related]
8. Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani. Characterization of microsomal galactosyltransferase and mannosyltransferase activities.
Carver MA; Turco SJ
J Biol Chem; 1991 Jun; 266(17):10974-81. PubMed ID: 1904057
[TBL] [Abstract][Full Text] [Related]
9. Ricin-resistant mutants of Leishmania major which express modified lipophosphoglycan remain infective for mice.
Cappai R; Morris L; Aebischer T; Bacic A; Curtis JM; Kelleher M; McLeod KS; Moody SF; Osborn AH; Handman E
Parasitology; 1994 May; 108 ( Pt 4)():397-405. PubMed ID: 8008453
[TBL] [Abstract][Full Text] [Related]
10. Cell surface lipophosphoglycan of Leishmania donovani.
King DL; Chang YD; Turco SJ
Mol Biochem Parasitol; 1987 May; 24(1):47-53. PubMed ID: 3614272
[TBL] [Abstract][Full Text] [Related]
11. Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania.
Basselin M; Robert-Gero M
Parasitol Res; 1998; 84(1):78-83. PubMed ID: 9491432
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lipophosphoglycan from a ricin-resistant mutant of Leishmania major.
Opat A; Ng K; Currie G; Handman E; Bacic A
Glycobiology; 1996 Jun; 6(4):387-97. PubMed ID: 8842702
[TBL] [Abstract][Full Text] [Related]
13. The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies.
Tolson DL; Turco SJ; Beecroft RP; Pearson TW
Mol Biochem Parasitol; 1989 Jun; 35(2):109-18. PubMed ID: 2475775
[TBL] [Abstract][Full Text] [Related]
14. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.
Mahoney AB; Sacks DL; Saraiva E; Modi G; Turco SJ
Biochemistry; 1999 Aug; 38(31):9813-23. PubMed ID: 10433687
[TBL] [Abstract][Full Text] [Related]
15. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages.
Dermine JF; Goyette G; Houde M; Turco SJ; Desjardins M
Cell Microbiol; 2005 Sep; 7(9):1263-70. PubMed ID: 16098214
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Mitochondrial Biogenesis and Metabolic Reprogramming Induced by Leishmania donovani Require Lipophosphoglycan and Type I Interferon Signaling.
Acevedo Ospina H; Guay-Vincent MM; Descoteaux A
mBio; 2022 Dec; 13(6):e0257822. PubMed ID: 36222510
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
Mukhopadhyay S; Sen P; Majumder HK; Roy S
J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani activates nuclear transcription factor-kappaB in macrophages through reactive oxygen intermediates.
Singh VK; Balaraman S; Tewary P; Madhubala R
Biochem Biophys Res Commun; 2004 Sep; 322(3):1086-95. PubMed ID: 15336576
[TBL] [Abstract][Full Text] [Related]
19. The leishmanial lipophosphoglycan: a multifunctional molecule.
Turco SJ
Exp Parasitol; 1990 Feb; 70(2):241-5. PubMed ID: 2404784
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of lipophosphoglycan from Leishmania major: characterization of (beta 1-3)-galactosyltransferase(s).
Ng K; Handman E; Bacic A
Glycobiology; 1994 Dec; 4(6):845-53. PubMed ID: 7734847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
